baber/WOPTO huggingface dataset:
Patent DE-69901537-T2 (DE)
Inventor: BERGSHOEFF DICK
IPC: B29C45/14
Filed: 1999-02-03
Granted: 2002-10-17
Abstract: A method of fabricating a support provided with shielding against interfering radiation, such as electromagnetic radiation, according to the invention involves a metallized plastic substrate, the metal comprising tin, being placed into an injection mould, and a plastic being injected into the mould to form the support. The tin-coated plastic substrate can be deformed very readily, so that it can be deformed three-dimensionally without its shielding characteristics being impaired.
Patent DE-69902158-T2 (DE)
Inventor: HENDRICKS S
IPC: H04H20/00
Filed: 1999-04-01
Granted: 2003-04-03
Abstract: A novel multiple channel architecture (265) is designed to allow targeted advertising directed to television terminals (220) connected to an operations center (202) or a cable headend (208). Program channels carry television programs. The invention uses upstream data reception hardware (262, 275, 297), databases (301) and processing hardware (285, 293) and software to accomplish these functions. During commercial breaks in the television programs, advertisements, which are also broadcast on the program channel, are displayed. However, additional feeder channels carry alternate advertising that may be better suited for certain viewing audiences. The operations center (202) or the cable headend (208) generate a group assignment plan (293, 299) that assigns the television terminals (220) to groups, based on factors such as area of dominant influence and household income. A switching plan (291) is then generated that instructs the television terminals (220) to remain with the program channel or to switch to one of the altemate feeder channels during the program breaks. The television terminals (220) record which channels were viewed during the program breaks, and report this information to the cable headend (208) and the operations center (202). The reported information is used to generate billing for commercial advertisers, and to analyze viewer watching habits.
Patent DE-69908156-T2 (DE)
Inventor: HOUZE B
IPC: C07D249/14
Filed: 1999-09-21
Granted: 2003-12-24
Abstract: The invention provides compounds, compositions and methods relating to novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular restenosis, infections, atherosclerosis and hypercholesterolemia, or as lead compounds for the development of such agents.
Patent DE-69914384-T2 (DE)
Inventor: CHARPENTIER PIERRE-EMMANUEL
IPC: C22B7/02
Filed: 1999-02-12
Granted: 2004-12-02
Abstract: A zinc-containing waste treatment process involves neutralizing (40) part of a used leaching solution, after zinc electrowinning (26), with waste acid to form a zinc-rich hydroxide sludge for recycling (50) to the leaching stage. A zinc-containing waste treatment process comprises (a) alkaline leaching (2) of the waste (8); (b) purification of the leach solution especially by cementation (18); (c) extraction of the zinc especially by electrolysis (26); (d) direct recycling of only a first fraction of the used solution (36) containing dissolved parasitic components (especially chlorides and sulfates); and (e) neutralization (40) of a second fraction of the used solution with waste acid to form a zinc-rich metal hydroxide sludge which is separated (45) and recycled (50) to the leaching stage. An Independent claim is also included for an installation for carrying out the above process.
Patent DE-69916062-T2 (DE)
Inventor: WU H
IPC: C09C1/42
Filed: 1999-04-20
Granted: 2005-01-20
Abstract: A method for reducing the abrasion of a silica-containing calcined kaolin pigment by the controlled leaching of silica from the pigment, preferably by the use of a caustic solution to dissolve the silica out of the calcined kaolin. In another aspect of the invention, the brightness, opacity, or both of a calcined kaolin is increased by increasing the fineness of the kaolin feed supplied to the calciner. The combination of these methods results in the production of a calcined kaolin with low abrasion and high brightness and opacity. Another aspect of the invention concerns an improved method of filtration of dilatent materials such as the leached calcined clay.
Patent DE-69918319-T2 (DE)
Inventor: GIORDANO GIUSEPPE
IPC: A45D19/02
Filed: 1999-10-13
Granted: 2005-06-30
Abstract: The invention concerns an applicator (5) with its end part having a conical or polyhedral shape (1) which enables, when it is facing downwards to retain the product and to allow a lock of hair to be inserted into a slot (2) for treating it to modify the colour of the lock of hair.
Patent DE-69922219-T2 (DE)
Inventor: SALONEN ARTO
IPC: A47G25/06
Filed: 1999-09-01
Granted: 2005-12-01
Abstract: The invention relates to a clothes rack for keeping garments, bags and other such objects. The clothes rack comprises a locking bow (1) arranged to move with respect to a fastening frame (4) by means of a power unit (7) and moving elements connected thereto, and to press the objects to be kept against the fastening frame (4), whereby the objects cannot be stolen from between the locking bow (1) and the fastening frame (4). The self-locking moving elements that are designed to hold the locking bow (1) in its locking position although et power unit (7) is switched off prevent the locking bow (1) from being unauthorizedly unlocked.
Patent DE-69922997-T2 (DE)
Inventor: JENSEN BO SKAANING
IPC: A61P21/00
Filed: 1999-12-03
Granted: 2005-12-15
Abstract: The present invention relates to ion channel activating agents. More particularly, the present invention relates to a particular class of chemical compounds that has proven useful as openers of SKCa and IKCa channels. In further aspects, the present invention relates to the use of these SK/IK channel activating agents for the manufacture of medicaments and pharmaceutical compositions comprising the SK/IK channel activating agents. The SK/IK channel activating agents of the invention are useful for the treatment or alleviation of diseases and conditions associated with the SK/IK channels, in particular respiratory diseases such as asthma, cystic fibrosis, chronic obstructive pulmonary disease and rhinorrhea, convulsions, vascular spasms, coronary artery spasms, renal disorders, polycystic kidney disease, bladder spasms, urinary incontinence, bladder outflow obstruction, irritable bowel syndrome, gastrointestinal dysfunction, secretory diarrhea, ischaemia, cerebral ischaemia, ischaemic heart disease, angina pectoris, coronary heart disease, traumatic brain injury, psychosis, anxiety, depression, dementia, memory and attention deficits, Alzheimer's disease, dysmenorrhea, narcolepsy, Reynaud's disease, intermittent claudication, Sjorgren's syndrome, migraine, arrhythmia, hypertension, absence seizures, myotonic muscle dystrophia, xerostomi, diabetes type II, hyperinsulinemia, premature labor, baldness, cancer, and immune suppression.
Patent DE-69923472-T2 (DE)
Inventor: HILL W
IPC: B60H1/00
Filed: 1999-11-04
Granted: 2005-12-29
Abstract: The present invention relates to a dual zone solar sensor incorporating a calibratable diffuser overlying a vertically oriented circuit board having at least one photodetector affixed to either side of the circuit board in a vertical plane. Each detector preferably has a mutually exclusive hemispherical view. By mounting the photodetectors in the vertical plane, the dual zone solar sensor device is capable of providing information about the intensity of a source of incident solar radiation and the relative position of that source of radiation. While the angular responses of the photodetectors in their vertical orientation are very close to those desired by skilled artisans for a dual zone sensor, the addition of a diffuser that is slidable, and therefore calibratable, provides a method by which the angular response of each photodetector may be permanently calibrated to achieve a precise desired angular response. The present inventive combination of features eliminates the need for complex and bulky electronic signal processing circuitry and decreases the number of parts necessary to achieve functions previously achieved only by larger sensors having a far greater number of component parts.
Patent DE-69931483-T2 (DE)
Inventor: HALFORD WAYNE
IPC: A63H17/02
Filed: 1999-08-02
Granted: 2006-12-21
Abstract: A front portion (12) and rear portion (14) of a toy vehicle (10) are pivotally secured to each other by a pivot (32) and an over-center action spring mechanism (70). The front and rear portions define travel limit stops which secure the front and rear portions in a straight line arrangement in one direction of over-center spring action. Additional limit stops are provided in the opposite direction in which the front and rear portions are pivoted into a crash simulation configuration. In one embodiment, the pivotal attachment of the front and rear portions of the toy vehicle allows pivotal movement in the horizontal position while, in an alternate embodiment, the pivotal attachment between front portion and rear portion of the vehicle allows pivotal movement thereof in the vertical plane. In both instances, the over-center action of the spring mechanism operative upon the pivot provides a maintaining spring force for straight line configuration and for angled crash simulation configuration.
Patent DE-69935239-T2 (DE)
Inventor: MOHEBBI BEHZAD
IPC: H04W36/30
Filed: 1999-10-27
Granted: 2007-08-23
Abstract: A cellular communications network includes a mobile station and a plurality of base transceiver stations BTSs. The mobile station has a measurement section (281) which, when the mobile station is being served by a first BTS, provides respective signal measures (RSSi) for the first BTS and for at least one further BTS neighbouring the first BTS. Each signal measure indicates the performance of a communications channel between the mobile station and the BTS concerned. The mobile station also has a best-server selection section (282) which determines, in dependence upon the signal measures, a single one of the first and further BTSs with which the mobile station should communicate.
Patent HU-E032379-T2 (HU)
Title: Composition of tumour-associated peptides and related anti-cancer vaccine
Inventor: SINGH HARPREET
IPC: A61P35/00
Filed: 2008-07-25
Abstract: The present invention relates to immunotherapeutic peptides and their use in immunotherapy, in particular the immunotherapy of cancer. The present invention discloses tumour-associated T-helper cell peptide epitopes, alone or in combination with other tumour-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumour immune responses. In particular, the composition of the peptides of the present invention can be used in vaccine compositions for eliciting anti-tumour immune responses against colorectal cancer.
Patent HU-E033243-T2 (HU)
Title: Benzylamine derivatives
Inventor: ALLAN CHRISTINE ELIZABETH
IPC: A61P27/02
Filed: 2014-01-08
Abstract: FIELD: chemistry. 
     SUBSTANCE: invention relates to a compound of formula (I),  
       
     in which V is selected from C and N so that the aromatic ring containing V is phenyl or pyridine; R2 is absent when V is N; or, when present, R2 is selected from H, alkyl, alkoxy and halogen; R1 and R3 are independently selected from H, alkyl, alkoxy, halogen and CF 3 ; W, X, Y and Z are independently selected from C and N, so that the ring containing W, X, Y and Z is a five-membered aromatic heterocycle; where R5, R6 and R7 are independently absent or independently selected from H, alkyl, aryl and CF 3 ; P represents -C(R10)(R11)NH 2 ; A is selected from aryl and heteroaryl; alkyl is a linear saturated hydrocarbon containing up to 6 carbon atoms (C 1 -C 6 ), or a branched saturated hydrocarbon containing from 3 to 6 carbon atoms (C 3 -C 6 ); alkyl, optionally, may be substituted with -NR12R13; cycloalkyl is a monocyclic saturated hydrocarbon containing from 3 to 7 carbon atoms; alkoxy is a linear O-linked hydrocarbon containing from 1 to 6 carbon atoms (C 1 -C 6 ), or a branched O-linked hydrocarbon containing from 3 to 6 carbon atoms (C 3 -C 6 ); alkoxy, optionally, may be substituted with aryl; aryl is phenyl; aryl, optionally, may be substituted with a substituent selected from alkyl, alkoxy, halogen, CN, -morpholinyl, -piperidinyl, heteroaryl, aryl b , -O-aryl b , -CH 2 - aryl b , -(CH 2 ) 1-3 -heteroaryl, -CONR12R13, -(CH 2 ) 1-3 -NR14R15 and NR12R13; heteroaryl is a 5, 6, 9 or 10-membered mono- or bicyclic aromatic ring containing, where possible, 1 or 2 ring members, independently selected from N, S and O; heteroaryl, optionally, may be substituted with 1 or 2 substituents independently selected from alkyl, alkoxy, morpholinyl, aryl, -(CH 2 ) 1-3 -aryl, heteroaryl b  and NR12R13; values of other radicals are given in the patent claim. Invention also relates to a pharmaceutical composition, to the use of a compound, to a method for treating a disease or condition in which plasma kallikrein activity is involved. 
     EFFECT: technical result: obtaining novel compounds capable of inhibiting plasma kallikrein. 
     29 cl, 18 tbl, 7 ex
Patent TR-200000193-T2 (TR)
Title: Bir fırında yüksek ölçüde reaktif kirecin üretilmesi için işlem
Inventor: JR LLOYD L LAVELY
IPC: C01B13/18
Filed: 1998-07-21
Abstract: Bir kireç tasi kalsinasyon islemi, ince bölünmüs kireç tasi parçalarinin, bir firin içinde, bu parçaciklar bölüm içinden geçerken, çikis gazi akiminin sicakliginin minimum kalsinasyon sicakliginin (tipik olarak, 741-777 C) üstünde ve etkili sönmemis kireç kullanim/sülfasyon sicakliginin (tipik olarak, (871-982 C) altinda oldugu bir bir bölüm içine zerkedilmesini kapsamaktadir. Kalsiyum sülfat olusturmak üzere sonuçtaki kireç parçaciklari ve kükürt dioksit arasindaki reaksiyonlar en aza düsürülmektedir. Kirecin sinterlenmesi ve kompleks kalsiyum bilesigi olusumu da en aza düsürülmektedir. Sonuçtaki yüksek ölçüde reaktif kireç parçaciklari çikis gazi kükürt alma islemlerinde kullanilabilmektedir.
Patent TR-200001355-T2 (TR)
Inventor: MENTZEL EDGAR
IPC: A24D3/16
Filed: 1997-11-13
Abstract: The invention relates to a cigarette with a filter containing activated carbon. Said cigarette comprises a tobacco string wrapped in cigarette paper, a double filter having a string-side part consisting of a tissue paper containing carbon, and a peripherally extending filter ventilation zone and located in the mouth-side part made of cellulose acetate. The tissue paper of the string-side filter part is a very bulky paper which contains 20 to 50 % wt microfine powdered active carbon. The ratio of condensate retention capacities of the string-side filter part to the mouth-side filter part ranges from 1 to 2. The air permeability of the cigarette paper is comprised between 40 and 100 Coresta units and the filter ventilation grade is comprised between 5 and 60 %.
Patent TR-200002216-T2 (TR)
Inventor: JENSEN ERIK
IPC: F17C5/00
Filed: 1999-01-29
Abstract: The present invention relates to an installation for filling liquified gas into containers. In particular, the invention relates to an installation having a distributed power supply system for supplying power consuming parts of the installation. The invention further relates to an installation having a generator for generating power for supplying power consuming parts of the installation.
Patent TR-200100461-T2 (TR)
Inventor: WYSS MARTIN
IPC: A47K4/00
Filed: 1999-08-10
Abstract: A device consisting of a combination of a bathtub (1) with a shower tray (3), in which the bathtub (1), when in position B=Bathing, is positioned over shower tray (3) in such a way that its water outlet ends up over the shower tray (3), whilst when in the other possible position S=Showering, it stands upright, i.e. end over end, on one of its ends, thereby freeing access to shower tray (3). Bathtub (1) can easily be manoeuvred from one position to the other by a lifting mechanism and the application of force, preferably generated by an electric motor (13). By completely separating the bathtub from the shower tray and by positioning the bathtub over the shower tray, the edge of the shower tray is on the one hand kept as low as it would be if there were indeed a separate shower tray, whilst on the other hand, the edge of the bathtub is only slightly raised. As a result, both parts are extremely user-friendly, especially for elderly or handicapped persons. The device does not require any more space than a conventional bathtub alone whilst also providing an additional full shower facility in the same space.
Patent TR-200101663-T2 (TR)
Title: Pro-kollajen c-proteinaz inhibitörleri
Inventor: DANKWARDT SHARON MARIE
IPC: C07K14/78
Filed: 1999-12-06
Abstract: Bu bulus, pro-kollajen C-proteinazin inhibitörleri olan, R1-R7, A, Z ve n nin bulusun özetinde tarif edildigi gibi oldugu Formül (I)'in bilesikleri ile, bunlari içeren farmasötik bilesimler, bunlarin kullanimlari için yöntemler ve bunlarin hazirlanmalari için yöntemler ile ilgilidir. Formül (I).
Patent TR-200101903-T2 (TR)
Title: Yeni malonik asit türevleri, bunların preparasyon işlemleri.
Inventor: DEFOSSA ELISABETH
IPC: C07D257/12
Filed: 1999-12-23
Abstract: Mevcut bulus, kan pihtilastirma proteinlerinin önlenmesine yönelik yeni bilesiklerle ve daha özel olarak R(1), R(2), R(3), R(4), R(5) ve R(6)'nin istemlerden belirtilen anlamlara geldigi formül (I)'e ait malonik asit türevleriyle ilgilidir. Formül (I)'e ait bilesikler, kan pihtilastirici enzim faktör Xa'nin önleyicileridir. Bulus, formül (I)'e ait bilesiklerin preparasyon islemleriyle, faktör Xa aktivitesinin önlenmesine ve kan pihtilasmasinin önlenmesine yönelik metotlar, tromboembolik hastaliklar gibi faktör Xa aktivitesinin önlenmesiyle tedavi edilebilen veya engellenebilen hastaliklarin tedavisinde ve profilaksisinde formül (I)'e ait bilesiklerin kullanilmasiyla, ve formül (I)'e ait bilesiklerin, bu hastaliklarda uygulanabilecek ilaçlarin preparasyonunda kullanilmasiyla da ilgilidir
Patent TR-200103096-T2 (TR)
Inventor: RICKETTS NIGEL JEFFRIE
IPC: B22D21/02
Filed: 2000-04-28
Abstract: A cover gas composition for protecting molten magnesium/magnesium alloy includes a fluorine containing inhibiting agent and a carrier gas. Each component of the composition has a Global Warming Potential (GWP) (referenced to the absolute GWP for carbon dioxide at a time horizon of 100 years) of less than 5000.
Patent TR-200201493-T2 (TR)
Title: Zarla süzmede sağlanan ilerlemeler.
Inventor: LANGLAIS CHRYSTELLE
IPC: C02F1/52
Filed: 2000-10-26
Abstract: Bu bulus, özellikle su olan, süspansiyona alinmis madde ihtiva eden atik çikis maddelerinin zarla süzülmesi, özellikle, mikro-,ultra-,nano- ya da hiper-süzülmesi için zarlarda saglanan gelismelere iliskindir. Bahsedilen gelismelerin amaci, zarlarin tikanmasinin düsürülmesi ve süzme kapasitesinin gelistirilmesidir. Gelistirimlerin özelligi, zar üzerinden geçmeden önce atik maddeye bir pihtilastirici tepkin maddenin bir dozunun eklenmesini kapsamalaridir. Bu tepkin madde süspansiyon içindeki koloidal maddeleri destabilize etmektedir. Doz, Zeta potansiyelinin sifir yapilmasi için gereken doza göre 30-80 misli daha az olmaktadir.
Patent TR-200201647-T2 (TR)
Title: Tekstil malzemeden dağıtma yoluyla uygulanmış fazlalık boyanın çıkarılması
Inventor: SHI CAROLINE
IPC: D06L4/40
Filed: 2000-12-22
Abstract: Bu bulus, baskili ya da boyali tekstil malzemeden dagitma yoluyla uygulanmis fazlalik boyanin çikarilmasi için, peroksidaz aktivitesi ya da lakkaz aktivitesine sahip enzimlerden meydana gelen gruptan seçilen en az bir enzim, bir oksidasyon maddesi ve en az bir araci maddeden meydana gelen bir durulama sivisi ile tretmandan meydana gelen bir yöntem saglar.
Patent TR-200403498-T2 (TR)
Inventor: BROWNING JEFFREY
IPC: A61P31/18
Filed: 2001-01-25
Abstract: Stimulating B-cell growth, immunoglobulin production, or dendritic cell-induced B-cell growth and maturation, or co-stimulating B-cell growth and immunoglobulin production, comprising administering a composition containing the tumor necrosis factor family B cell activating factor (BAFF) or its active fragment, and optionally an anti-Micro antibody, a CD40 ligand or an anti-CD40 ligand, is new. An independent claim is also included for a method of inhibiting B-cell growth, immunoglobulin production, or dendritic cell-induced B-cell growth, or co-inhibiting B-cell growth and immunoglobulin production, comprising administering an anti-BAFF ligand molecule, a recombinant, inoperative BAFF ligand molecule, an antibody specific for BAFF ligand, active fragments of the molecules, or an antibody specific for BAFF ligand receptor, or an epitope of it. ACTIVITY : Immunosuppressive; virucide; antiinflammatory; hypotensive; nephrotropic; cardiant; cytostatic. No biological data is given. MECHANISM OF ACTION : B-cell growth and/or immunoglobulin production stimulators or inhibitors.
Patent DE-602004001676-T2 (DE)
Inventor: BRAGANZA JOHN FREDERICK
IPC: C07D471/04
Filed: 2004-02-03
Granted: 2007-08-30
Abstract: The present invention relates to novel triazolo-pyridines of the formula wherein X is >CH<SUB>2</SUB>, >NH, sulfur, >S-O, >SO<SUB>2 </SUB>or oxygen; wherein said >CH<SUB>2 </SUB>and >NH may optionally be substituted with a suitable substituent; R<SUP>1 </SUP>is selected from the group consisting of hydrogen, (C<SUB>1</SUB>-C<SUB>6</SUB>)alkyl and other suitable substituents; R<SUP>2 </SUP>is selected from the group consisting of hydrogen, (C<SUB>1</SUB>-C<SUB>6</SUB>)alkyl and other suitable substituents; s is an integer from 0-4; R<SUP>3 </SUP>is R<SUP>4</SUP>, R<SUP>5</SUP>-(NR<SUP>6</SUP>)-, R<SUP>5</SUP>-S-, R<SUP>5</SUP>-(S-O)-, R<SUP>5</SUP>-(SO<SUB>2</SUB>)-, R<SUP>5</SUP>-SO<SUB>2</SUB>-NR<SUP>6</SUP>-, R<SUP>5</SUP>-(NR<SUP>6</SUP>)-SO<SUB>2</SUB>-, R<SUP>5</SUP>-O-, R<SUP>5</SUP>-(C-O)-, R<SUP>5</SUP>-(NR<SUP>6</SUP>)-(C-O)-, R<SUP>5</SUP>-(C-O)-NR<SUP>6</SUP>-, R<SUP>5</SUP>-O-(C-O)-, R<SUP>5</SUP>-(C-O)-O-, R<SUP>5</SUP>-CR<SUP>7</SUP>-CR<SUP>8</SUP>- or R<SUP>5</SUP>-C≡C-; such that the molecular weight of R<SUP>3 </SUP>is less than 500 AMU, preferably less than 250 AMU; R<SUP>4</SUP>, R<SUP>5 </SUP>and R<SUP>6 </SUP>are each selected from the group consisting of hydrogen, (C<SUB>1</SUB>-C<SUB>6</SUB>)alkyl and other suitable substituents; or a pharmaceutically acceptable salt thereof; to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use. The compounds of the present invention are potent inhibitors of MAP kinases. They are useful in the treatment of inflammation, osteoarthritis, rheumatoid arthritis, cancer, reperfusion or ischemia in stroke or heart attack, autoimmune diseases and other disorders.
Patent DE-602004003241-T2 (DE)
Inventor: EBEL JAMES PATRICK
IPC: A61K31/164
Filed: 2004-06-14
Granted: 2007-05-31
Abstract: The present invention is directed to a method of promoting sleep by topically applying onto the skin a composition that comprises a non-hypnotic, vasoactive agent. The non-hypnotic, vasoactive agent is highly effective in providing for the improved quality of sleep through the use of topical application.